Wuhan Easy Diagnosis Biomedicine Co., Ltd. is engaged in the research, development, production and sales of POCT rapid diagnostic reagents and rapid detection instruments. Its products include Blood Gas Analysis, ImmunoDiagnosis, Molecular Diagnosis and Coagulation Analysis. The company was founded on January 28, 2008 and is headquartered in Wuhan, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company